Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.

American journal of clinical oncology2000Ahmed S, Vaitkevicius VK, Zalupski MM, et al.

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2000
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdenocarcinomaAdultAgedAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCA-19-9 AntigenCaffeineCisplatinConfidence IntervalsCytarabineFemaleFluorouracilHumansMaleMiddle AgedNeutropeniaPancreatic NeoplasmsPhosphodiesterase InhibitorsRemission InductionSurvival RateThrombocytopenia

DOI 10.1097/00000421-200008000-00022

PMID 10955876

View source →